NO306993B1 - Piperidinylmetyloksyzolidin-2-on-derivater, farmasoeytiske preparater som inneholder slike, samt anvendelse av forbindelsene til fremstilling av legemidler - Google Patents

Piperidinylmetyloksyzolidin-2-on-derivater, farmasoeytiske preparater som inneholder slike, samt anvendelse av forbindelsene til fremstilling av legemidler

Info

Publication number
NO306993B1
NO306993B1 NO963524A NO963524A NO306993B1 NO 306993 B1 NO306993 B1 NO 306993B1 NO 963524 A NO963524 A NO 963524A NO 963524 A NO963524 A NO 963524A NO 306993 B1 NO306993 B1 NO 306993B1
Authority
NO
Norway
Prior art keywords
piperidinylmethyloxyzolidin
derivatives
compounds
manufacture
pharmaceutical preparations
Prior art date
Application number
NO963524A
Other languages
English (en)
Norwegian (no)
Other versions
NO963524L (no
NO963524D0 (no
Inventor
Helmut Pruecher
Gerd Bartoszyk
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO963524D0 publication Critical patent/NO963524D0/no
Publication of NO963524L publication Critical patent/NO963524L/no
Publication of NO306993B1 publication Critical patent/NO306993B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO963524A 1995-08-25 1996-08-23 Piperidinylmetyloksyzolidin-2-on-derivater, farmasoeytiske preparater som inneholder slike, samt anvendelse av forbindelsene til fremstilling av legemidler NO306993B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19531321A DE19531321A1 (de) 1995-08-25 1995-08-25 Piperidinylmethyloxazolidinone

Publications (3)

Publication Number Publication Date
NO963524D0 NO963524D0 (no) 1996-08-23
NO963524L NO963524L (no) 1997-02-26
NO306993B1 true NO306993B1 (no) 2000-01-24

Family

ID=7770390

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963524A NO306993B1 (no) 1995-08-25 1996-08-23 Piperidinylmetyloksyzolidin-2-on-derivater, farmasoeytiske preparater som inneholder slike, samt anvendelse av forbindelsene til fremstilling av legemidler

Country Status (27)

Country Link
US (1) US5714502A (cs)
EP (1) EP0763535B1 (cs)
JP (1) JPH09124646A (cs)
KR (1) KR970010766A (cs)
CN (1) CN1067391C (cs)
AR (1) AR004185A1 (cs)
AT (1) ATE228517T1 (cs)
AU (1) AU715310B2 (cs)
BR (1) BR9603509A (cs)
CA (1) CA2184052A1 (cs)
CO (1) CO4750661A1 (cs)
CZ (1) CZ291446B6 (cs)
DE (2) DE19531321A1 (cs)
DK (1) DK0763535T3 (cs)
ES (1) ES2187597T3 (cs)
HU (1) HUP9602324A3 (cs)
MX (1) MX9603567A (cs)
NO (1) NO306993B1 (cs)
PL (1) PL185141B1 (cs)
PT (1) PT763535E (cs)
RU (1) RU2175970C2 (cs)
SI (1) SI0763535T1 (cs)
SK (1) SK281914B6 (cs)
TR (1) TR199600656A2 (cs)
TW (1) TW426680B (cs)
UA (1) UA43860C2 (cs)
ZA (1) ZA967201B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19739332C1 (de) * 1997-09-09 1998-11-26 Merck Patent Gmbh Piperidinylmethyloxazolidinon-Derivat
US6642256B2 (en) * 2000-12-21 2003-11-04 Warner-Lambert Company Llc Piperidine derivatives as subtype selective N-Methyl-D-Aspartate antagonists
TW200302095A (en) * 2002-01-25 2003-08-01 Upjohn Co Oxazolidinone cotherapy
ATE430976T1 (de) * 2003-07-14 2009-05-15 Lg Electronics Inc Einmalbeschreibbarer optischer datenträger, verfahren und vorrichtung zum aufzeichnen von verwaltungsinformationen auf einem einmalbeschreibbaren optischen datenträger
GB201317609D0 (en) 2013-10-04 2013-11-20 Cancer Rec Tech Ltd Inhibitor compounds
GB201505658D0 (en) 2015-04-01 2015-05-13 Cancer Rec Tech Ltd Inhibitor compounds
GB201617103D0 (en) 2016-10-07 2016-11-23 Cancer Research Technology Limited Compound

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0713017B2 (ja) * 1986-06-18 1995-02-15 日本ケミファ株式会社 脳細胞保護作用を有する医薬組成物
DE3723797A1 (de) * 1987-07-18 1989-01-26 Merck Patent Gmbh Oxazolidinone
DE4005371A1 (de) * 1990-02-21 1991-08-22 Merck Patent Gmbh Oxazolidinone
DE4017211A1 (de) * 1990-05-29 1991-12-05 Merck Patent Gmbh Oxazolidinone
DE4324393A1 (de) * 1993-07-21 1995-01-26 Merck Patent Gmbh 4-Aryloxy- und 4-Arylthiopiperidinderivate

Also Published As

Publication number Publication date
HUP9602324A3 (en) 1998-10-28
CZ291446B6 (cs) 2003-03-12
TW426680B (en) 2001-03-21
DK0763535T3 (da) 2003-03-17
AR004185A1 (es) 1998-11-04
MX9603567A (es) 1997-06-28
CN1148594A (zh) 1997-04-30
HUP9602324A2 (hu) 1998-07-28
DE59609913D1 (de) 2003-01-09
EP0763535B1 (de) 2002-11-27
BR9603509A (pt) 1998-05-12
CN1067391C (zh) 2001-06-20
NO963524L (no) 1997-02-26
TR199600656A2 (tr) 1997-03-21
PT763535E (pt) 2003-04-30
JPH09124646A (ja) 1997-05-13
CZ233896A3 (en) 1997-03-12
HU9602324D0 (en) 1996-10-28
EP0763535A1 (de) 1997-03-19
KR970010766A (ko) 1997-03-27
TR199600656A3 (cs) 1997-03-21
ATE228517T1 (de) 2002-12-15
RU2175970C2 (ru) 2001-11-20
CA2184052A1 (en) 1997-02-26
US5714502A (en) 1998-02-03
SK281914B6 (sk) 2001-09-11
AU6215196A (en) 1997-02-27
CO4750661A1 (es) 1999-03-31
UA43860C2 (uk) 2002-01-15
ZA967201B (en) 1997-03-03
SI0763535T1 (en) 2003-08-31
DE19531321A1 (de) 1997-02-27
PL185141B1 (pl) 2003-02-28
PL315801A1 (en) 1997-03-03
AU715310B2 (en) 2000-01-20
ES2187597T3 (es) 2003-06-16
SK106196A3 (en) 1997-04-09
NO963524D0 (no) 1996-08-23

Similar Documents

Publication Publication Date Title
EE04021B1 (et) 7a-( -aminoalküül)östratrieenid, nende valmistamise meetod, 7a-( -aminoalküül)östratrieene sisaldavad farmatseutilised preparaadid ja nende kasutamine ravimite valmistamiseks
NO305903B1 (no) Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater
ATE248594T1 (de) Irbesartanhaltiges arzneimittel
FI973278A7 (fi) Uudet farnesyylitransferaasin inhibiittorit, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet
EE9400455A (et) Peptiidi derivaadid, nende valmistamise protsess, neid sisaldavad ravimpreparaadid ja nende kasutamine
FI943570A0 (fi) 1-bentseenisulfonyyli-1,3-dihydroindol-2-onijohdannaisia, niiden valmistus ja niitä sisältäviä lääkeaineita
NO944700D0 (no) Nye tienotiazinderivater, fremgangsmåte for fremstilling derav samt farmasöytiske preparater inneholdende forbindelsene
NO982580D0 (no) Nye taxoider, deres fremstilling samt farmas°ystiske preparater inneholdende taxoidene
NO308107B1 (no) Ikke-solvatert krystallinsk forbindelse, farmasøytisk formulering inneholdende denne samt anvendelse av forbindelsen for fremstilling av et farmasøytisk middel
NO307925B1 (no) Bicykliske aromatiske forbindelser, anvendelse derav, og farmasøytiske og kosmetiske preparater
BR9607851B1 (pt) combinaÇço e formulaÇço farmacÊutica.
NO305906B1 (no) Adhesjonsreseptorantagonister, farmasöytiske preparater som inneholder slike forbindelser, samt anvendelse av forbindelsene til fremstilling av legemidler
BR9602915A (pt) Medicamentos uso e formulação farmacêutica
FI931336A7 (fi) Polyhydroksimetyleenijohdannaisia sisältäviä lääkkeitä, menetelmä niiden valmistamiseksi ja käyttämiseksi
FI945975A7 (fi) Haarautuneella aminoryhmällä substituoituja tiatsoleja, menetelmiä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia
FI954111A7 (fi) Uudet taksoidit, niiden valmistus ja niitä sisältävät farmaseuttiset v almisteet
NO965102L (no) Bicykliske aromatiske forbindelser, anvendelser derav, og farmasöytiske og kosmetiske preparater
NO306113B1 (no) Adhesjonsreseptorantagonister, farmasöytiske preparater som inneholder slike forbindelser, samt anvendelse av forbindelsene til fremstilling av legemidler
NO305286B1 (no) Kinoksalinforbindelser, farmas°ytiske preparater som omfatter dem, og anvendelse derav for fremstilling av medikamenter
FI961938A7 (fi) Uudet taksoidit, niiden valmistus ja niitä sisältävät farmaseuttiset v almisteet
NO308251B1 (no) Karbohydratderivater, farmasøytisk blanding inneholdende karbohydratderivater samt anvendelse av samme
NO306993B1 (no) Piperidinylmetyloksyzolidin-2-on-derivater, farmasoeytiske preparater som inneholder slike, samt anvendelse av forbindelsene til fremstilling av legemidler
FI951961L (fi) Tilidiinidivetyortofosfatti, menetelmä sen valmistamiseksi ja sitä sisältäviä farmaseuttisia valmisteita
NO305793B1 (no) 4-aminobenzoylguanidiner, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, samt anvendelse av forbindelsene til fremstilling av legemidler
DK163121C (da) 1-benzazepin-2-on-derivater, farmaceutiske praeparater indeholdende saadanne samt anvendelse af dem til fremstilling af praeparaterne